Lapalombella et al. Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood. 2008;112(13):5180–5189.

Lignende værker

• Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells
  af: Lapalombella, Rosa, et al.
  Udgivet: (2008)
• Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813.
  Udgivet: (2009)
• Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4(+) lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287-294.
  Udgivet: (2014)
• Ibrutinib antagonizes rituximab-dependent NK cell–mediated cytotoxicity
  af: Kohrt, Holbrook E., et al.
  Udgivet: (2014)
• Mayack SR, Wagers AJ. Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood. 2008;112(3):519–531.
  Udgivet: (2012)